LncRNA FLG-AS1 inhibits esophageal squamous cell carcinoma by regulating the miR-23a-3p/HOXD10 axis
FLG-AS1 effectively inhibits the progression of ESCC and counters cisplatin resistance through the modulation of the miR-23a-3p/HOXD10 axis. This is a new mechanism affecting ESCC and will provide new ideas for the targeted therapy of ESCC.
Authors
- Fucheng Zhang (ORCID: https://orcid.org/0000-0001-7851-5432)
- Xiaoling Song (ORCID: https://orcid.org/0000-0001-8654-2932)
- Zhigao Zhang (ORCID: https://orcid.org/0000-0002-0365-8727)
- Chun Jason Xue (ORCID: https://orcid.org/0000-0002-6431-9868)
- Yaojun Wang (ORCID: https://orcid.org/0000-0002-6183-6587)
Institutions
- Union Hospital (HK)
- Second Hospital of Shandong University (CN)
Publication Details
- Journal
- Hereditas
- Published
- 2025-06-03
- DOI
- https://doi.org/10.1186/s41065-025-00461-0
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00